Dyne Therapeutics, Inc. DYN Weighted Average Limited Partnership Units Outstanding
Weighted Average Limited Partnership Units Outstanding at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageLimitedPartnershipUnitsOutstanding.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding?
- Dyne Therapeutics, Inc. (DYN) reported weighted average limited partnership units outstanding of 165M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding changed year-over-year?
- Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding increased by 50.2% year-over-year, from 109.9M to 165M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding?
- Over 3 years (2022 to 2025), Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding has grown at a 33.6% compound annual growth rate (CAGR), from 207.1M to 494M.
- What does weighted average limited partnership units outstanding mean?
- This metric represents the average number of limited partnership units outstanding during the reporting period, calculated by weighting the units by the portion of the period they were outstanding. It serves as the denominator for calculating basic earnings per unit for entities structured as limited partnerships. This figure is essential for investors to understand the equity base used to distribute earnings or losses to partners.